Rallybio Corporation (RLYB)

AI Score

Unlock

0.25

-0.00 (-0.71%)

At close: Apr 17, 2025, 3:57 PM

0.25

1.25%

After-hours: Apr 17, 2025, 07:50 PM EDT

Rallybio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	13.9M	25.32M	16.67M	19.3M	24.49M	19.16M	32.56M	39.52M	56.96M	132.42M	60.75M	81.42M	175.33M	186.98M	112.73M	127.74M	140.23M	-19.46M
Short-Term Investments	51.61M	49.82M	71.94M	74.87M	85.44M	102.23M	105.28M	110.87M	112.04M	80.71M	86.61M	79.98M	n/a	n/a	n/a	n/a	n/a	38.92M
Long-Term Investments	n/a	431K	568K	304K	239K	102K	n/a	217K	30K	244K	227K	415K	805K	1.03M	1.36M	328K	310K	n/a
Other Long-Term Assets	n/a	n/a	-1	-1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-19.46M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	995K	1.75M	2.82M	768K	4.86M	3.59M	9M	10.89M	1.05M	10.01M	6.93M	6.37M	5.54M	5.41M	5.7M	n/a	n/a	n/a
Total Current Assets	67.84M	78.23M	91.44M	98.55M	114.79M	132.42M	146.83M	161.28M	179.5M	142.43M	154.3M	167.78M	180.87M	192.39M	118.43M	128.71M	141.26M	19.46M
Property-Plant & Equipment	267K	346K	427K	510K	592K	670K	742K	825K	909K	993K	1.08M	1.16M	511K	445K	306K	312K	287K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	267K	777K	995K	814K	831K	772K	742K	1.04M	939K	1.24M	1.31M	1.57M	1.32M	1.47M	1.67M	640K	597K	-19.46M
Total Assets	68.11M	79.01M	92.43M	99.36M	115.62M	133.19M	147.58M	162.32M	180.44M	143.67M	155.61M	169.35M	182.19M	193.87M	120.1M	129.35M	141.86M	n/a
Account Payables	278K	583K	1.22M	470K	976K	464K	689K	782K	1.11M	828K	633K	1.06M	603K	2.6M	2.62M	3.01M	1.58M	n/a
Deferred Revenue	848K	1.1M	1.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-150K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	226K	n/a	219K	217K	213K	197K	n/a	165K	150K	148K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.1M	6.28M	6.53M	5.51M	4.68M	5.18M	4.7M	4.21M	4.7M	5.96M	3.67M	3.4M	2.99M	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	6.24M	8.19M	12.16M	10.09M	9.26M	9.4M	8.05M	6.8M	10.74M	11.29M	7.28M	5.8M	6.55M	7.34M	7.41M	6.08M	5.84M	n/a
Long-Term Debt	n/a	n/a	58K	n/a	173K	211K	266K	321K	n/a	428K	478K	517K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-58K	n/a	-173K	-211K	-266K	-321K	n/a	-428K	-478K	-517K	32K	35K	182.05M	182.05M	182.04M	n/a
Total Long-Term Liabilities	212K	n/a	253K	116K	173K	211K	266K	321K	374K	428K	478K	517K	32K	35K	182.05M	182.05M	182.04M	n/a
Total Liabilities	6.45M	8.19M	12.41M	10.2M	9.44M	9.61M	8.32M	7.12M	11.12M	11.72M	7.76M	6.32M	6.58M	7.38M	189.46M	188.13M	187.88M	n/a
Total Debt	154K	230K	284K	339K	392K	428K	479K	518K	555K	593K	628K	665K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	4K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	3K	3K	3K	2.05M	1.51M	2K	n/a
Retained Earnings	-293.02M	-281.98M	-270.51M	-254.27M	-235.25M	-215M	-196.63M	-178M	-160.68M	-144.48M	-126.11M	-108.53M	-94.03M	-81.61M	-71.42M	-60.29M	-47.01M	n/a
Comprehensive Income	68K	169K	-71K	-71K	15K	-208K	-272K	-61K	-214K	-434K	-371K	-122K	0.00	-0.00	1.51M	1.02M	-0.00	-20.28M
Shareholders Equity	61.65M	70.82M	80.02M	89.16M	106.18M	123.58M	139.26M	155.2M	169.32M	131.94M	147.85M	163.04M	175.6M	186.49M	112.66M	-60.29M	-47.01M	16.86M
Total Investments	51.61M	50.25M	72.51M	75.18M	85.67M	102.23M	105.28M	111.09M	112.07M	80.95M	86.84M	80.4M	805K	1.03M	1.36M	328K	310K	38.92M